Propofol and Midazolam in the Treatment of Refractory Status Epilepticus
Open Access
- 9 March 2001
- Vol. 42 (3) , 380-386
- https://doi.org/10.1046/j.1528-1157.2001.27500.x
Abstract
Summary: Purpose: To explore outcome differences between propofol and midazolam (MDL) therapy for refractory status epilepticus (RSE). Methods: Retrospective chart review of consecutive patients tr...Keywords
This publication has 28 references indexed in Scilit:
- Propofol for refractory status epilepticusIntensive Care Medicine, 1994
- Propofol in the management of refractory status epilepticus: A case reportIntensive Care Medicine, 1994
- Refractory status epilepticus in adultsAnnals of Emergency Medicine, 1993
- Advances in the management of refractory status epilepticusCritical Care Medicine, 1993
- Generalized Convulsive Status Epilepticus in the AdultEpilepsia, 1993
- Distribution of HSP72 induction and neuronal death following limbic seizuresNeuroscience Letters, 1992
- Intravenous midazolam for the treatment of refractory status epilepticusCritical Care Medicine, 1992
- Successful use of propofol in status epilepticusAnaesthesia, 1990
- Propofol infusions for status epilepticusAnaesthesia, 1988
- APACHE IICritical Care Medicine, 1985